The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a ...

ICON Public Limited Company ... stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including ...

On a night packed with drama, milestones, and momentum swings, five batters rose above the rest to set Eden Gardens alight.

SPORT has you covered for all the latest football news as domestic football makes a return this weekend. In some blockbuster ...

On Donald Trump, the geopolitical upheaval and the duping of our continent. Likewise, a warning against the rhetoric of ...

A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...

Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Medetomidine is used in veterinary medicine, often during surgery. It's becoming common in the city's drug supplies, and it ...

A significant benefit was observed with Tysabri over Rebif in delaying SPMS disability progression when therapeutic lag was ...

Bayer and Suzhou Puhe BioPharma Co. Ltd., a clinical-stage biotechnology company ... Bayer has enrolled the first participant in a Phase I first-in-human dose escalation study investigating ...